Please login to the form below

Not currently logged in
Email:
Password:

diagnostics

This page shows the latest diagnostics news and features for those working in and with pharma, biotech and healthcare.

Novacyt launches diagnostic test to differentiate between COVID-19 and flu

Novacyt launches diagnostic test to differentiate between COVID-19 and flu

Test launches in time for upcoming winter flu season. Biotech company Novacyt has announced the launch of a new diagnostic test which can tell the difference between COVID-19 and the ... The clinical diagnostics company said that its Winterplex test

Latest news

More from news
Approximately 35 fully matching, plus 637 partially matching documents found.

Latest Intelligence

  • The global antibiotic crisis: a 2020 perspective The global antibiotic crisis: a 2020 perspective

    by 2024. The plan also supports increased use of a ‘precision medicines’ approach increasing the percentage of prescriptions informed by diagnostics and decision support tools.

  • Staying ahead in the era of precision medicine Staying ahead in the era of precision medicine

    new diagnostic and therapeutic technology means that this rapidly evolving field has implications for all aspects of the healthcare and medical research ecosystem.

  • It started with a miss It started with a miss

    one, to uncover their perspectives on everything from their disease experience and diagnostic pathways, to the things that prevent treatment and the real-world implications of taking a medicine.

  • A snapshot of Congenica A snapshot of Congenica

    Additionally, there is a reduction in the overall cost that comes with repeated failed diagnostic procedures and inappropriate treatments. ... Our technology is significantly increasing the diagnostic yield and reducing the time to diagnosis in rare and

  • Tackling antimicrobial resistance on multiple fronts Tackling antimicrobial resistance on multiple fronts

    Developers and investors are not convinced that health systems and individuals will be ready to buy new diagnostics. ... Simply put, the current economic set-up makes development of both diagnostics and antibiotics unviable.

More from intelligence
Approximately 3 fully matching, plus 139 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 73 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 5 fully matching, plus 98 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics